STOCK TITAN

IVERIC bio Inc - ISEE STOCK NEWS

Welcome to our dedicated news page for IVERIC bio (Ticker: ISEE), a resource for investors and traders seeking the latest updates and insights on IVERIC bio.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IVERIC bio's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IVERIC bio's position in the market.

Rhea-AI Summary
Astellas Pharma Inc. has completed the acquisition of IVERIC bio, Inc. Iveric Bio is now Astellas' wholly-owned subsidiary. The acquisition was completed on July 11, 2023, following all necessary approvals. Astellas aims to become a leader in the development and commercialization of treatments for retinal diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
acquisition
-
Rhea-AI Summary
Astellas Pharma Inc. has completed the acquisition of IVERIC bio, Inc. Iveric Bio is now Astellas' wholly-owned subsidiary. The acquisition was completed on July 11, 2023, following all necessary approvals. Astellas aims to become a leader in the development and commercialization of treatments for retinal diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-100%
Tags
acquisition
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.69%
Tags
acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.1%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.94%
Tags
earnings
IVERIC bio Inc

OTC:ISEE

ISEE Rankings

ISEE Stock Data

5.51B
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
New York

About ISEE

we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).